163 related articles for article (PubMed ID: 20300552)
1. Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies.
Khan S; Taylor JL; Rinker-Schaeffer CW
J Oncol; 2010; 2010():286925. PubMed ID: 20300552
[TBL] [Abstract][Full Text] [Related]
2. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
[TBL] [Abstract][Full Text] [Related]
4. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
5. In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose.
Krishnan V; Clark R; Chekmareva M; Johnson A; George S; Shaw P; Seewaldt V; Rinker-Schaeffer C
J Vis Exp; 2015 Oct; (105):e52721. PubMed ID: 26555178
[TBL] [Abstract][Full Text] [Related]
6. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
7. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization.
Krishnan V; Stadick N; Clark R; Bainer R; Veneris JT; Khan S; Drew A; Rinker-Schaeffer C
Cancer Metastasis Rev; 2012 Dec; 31(3-4):605-13. PubMed ID: 22706843
[TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
[TBL] [Abstract][Full Text] [Related]
9. The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.
Zhao L; Wang W; Huang S; Yang Z; Xu L; Yang Q; Zhou X; Wang J; Shen Q; Wang C; Le X; Feng M; Zhou N; Lau WB; Lau B; Yao S; Yi T; Wang X; Zhao X; Wei Y; Zhou S
Genome Biol; 2018 Mar; 19(1):35. PubMed ID: 29548303
[TBL] [Abstract][Full Text] [Related]
10. Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization.
Knopeke MT; Ritschdorff ET; Clark R; Vander Griend DJ; Khan S; Thobe M; Shear JB; Rinker-Schaeffer CW
FEBS Lett; 2011 Oct; 585(20):3159-65. PubMed ID: 21925502
[TBL] [Abstract][Full Text] [Related]
11. In vitro metastatic colonization of human ovarian cancer cells to the omentum.
Khan SM; Funk HM; Thiolloy S; Lotan TL; Hickson J; Prins GS; Drew AF; Rinker-Schaeffer CW
Clin Exp Metastasis; 2010 Mar; 27(3):185-96. PubMed ID: 20229256
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression.
Mitra S; Tiwari K; Podicheti R; Pandhiri T; Rusch DB; Bonetto A; Zhang C; Mitra AK
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600962
[TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor genes: from gene identification to protein function and regulation.
Berger JC; Vander Griend DJ; Robinson VL; Hickson JA; Rinker-Schaeffer CW
Cancer Biol Ther; 2005 Aug; 4(8):805-12. PubMed ID: 16082183
[TBL] [Abstract][Full Text] [Related]
14. Thinking outside the box: using metastasis suppressors as molecular tools.
Thiolloy S; Rinker-Schaeffer CW
Semin Cancer Biol; 2011 Apr; 21(2):89-98. PubMed ID: 21147228
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
16. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract][Full Text] [Related]
17. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
Mitra AK; Chiang CY; Tiwari P; Tomar S; Watters KM; Peter ME; Lengyel E
Oncogene; 2015 Nov; 34(48):5923-32. PubMed ID: 25798837
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
Zhao JZ; Wang G; Zhang RP; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
